Standout Papers

EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors 2009 2026 2014 2020 892
  1. EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors (2010)
    Young Lim Choi, Manabu Soda et al. New England Journal of Medicine
  2. KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer (2009)
    Kengo Takeuchi, Young Lim Choi et al. Clinical Cancer Research

Immediate Impact

4 by Nobel laureates 19 from Science/Nature 78 standout
Sub-graph 1 of 18

Citing Papers

Translating p53-based therapies for cancer into the clinic
2024 Standout
Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer
2024 Standout

Works of Toshihide Ueno being referenced

Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
2023
Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities
2021

Author Peers

Author Last Decade Papers Cites
Toshihide Ueno 1897 2090 2152 72 4.0k
Shin‐ichiro Fujiwara 1872 2438 2952 89 4.5k
Maria Cristina Manara 2871 1576 2314 117 5.5k
Ryohei Katayama 2800 3145 3138 84 5.3k
Diane Prager 1552 3429 3407 54 5.3k
Anne‐Marie Cleton-Jansen 2348 1741 2126 119 5.8k
Frank Hilberg 1931 1135 1170 56 3.9k
A. Linn Murphree 2948 2848 1217 77 7.0k
Kenneth S. Thress 2449 3336 3908 48 5.6k
Toru Mukohara 1679 2275 1609 125 3.9k
Maria Zieleńska 2948 1074 2146 148 5.4k

All Works

Loading papers...

Rankless by CCL
2026